Drug products: Dimor®, Imodium, Imodium Janssen-Cilag Ltd, Imodium N, Imodium®, Imolopera, Lopacut, Loperamid ABECE, Loperamid Apofri, Loperamid Brown, Loperamid Mylan, Loperamid NET, Loperamide Medical Valley
ATC code: A07DA03
Substances: loperamide, loperamide hydrochloride, loperamide oxide, loperamide oxide monohydrate
Controlled studies of differences between men and women are lacking for efficacy, safety, and pharmacokinetic properties for loperamide.
Pharmacokinetics and dosing
No studies with a clinically relevant sex analysis regarding the pharmacokinetics or dosing of loperamide have been found.
No studies with a clinically relevant sex analysis regarding the effects of loperamide have been found.
No studies with a clinically relevant sex analysis regarding adverse effects of loperamide have been found.
Reproductive health issues
Regarding teratogenic aspects, please consult Janusmed Drugs and Birth Defects (in Swedish, Janusmed fosterpåverkan).
Date of litterature search: 2015-06-02
- Läkemedelsstatistik. Stockholm: Socialstyrelsen. 2015 [cited 2016-04-05.] länk
Reviewed by: Mia von Euler
Approved by: Karin Schenck-Gustafsson